Inventor · disambiguated record
Mack Flinspach
Also filed as: FLINSPACH MACK
9 granted patents·4 pending applications·30 citations·filing 2003–2021
84Inventor score
Files withJANSSEN BIOTECH INC10TAKEDA PHAARMACEUTICAL COMPANY LTD1TAKEDA PHARMACEUTICALS CO1UNIV CALIFORNIA1
Top patents by PatentIndex Score
13 records- 0189US10995125B2Protoxin-II variants and methods of useJANSSEN BIOTECH INC·Filed 2017·Granted May 4, 2021·4 cites·20 claims
- 0285US9624280B2Protoxin-II variants and methods of useJANSSEN BIOTECH INC·Filed 2014·Granted Apr 18, 2017·6 cites·28 claims
- 0380US9102751B2Huwentoxin-IV variants and methods of useJANSSEN BIOTECH INC·Filed 2013·Granted Aug 11, 2015·7 cites·10 claims
- 0478US7056945B1Selective inhibition of neuronal nitric oxide synthaseUNIV CALIFORNIA·Filed 2003·Granted Jun 6, 2006·11 cites·14 claims
- 0576US10463714B2Protoxin-II variants and methods of useJANSSEN BIOTECH INC·Filed 2016·Granted Nov 5, 2019·2 cites·29 claims
- 0672US11083776B2Protoxin-II variants and methods of useJANSSEN BIOTECH INC·Filed 2019·Granted Aug 10, 2021·0 cites·24 claims
- 0767US2021363204A1Protoxin-ii variants and methods of useJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 0866US2022054590A1Protoxin-ii variants and methods of use thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 0958US10975129B2Protoxin-II variants and methods of useJANSSEN BIOTECH INC·Filed 2017·Granted Apr 13, 2021·0 cites·33 claims
- 1050US12122815B2GIP receptor agonist peptide compounds and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 22, 2024·0 cites·29 claims
- 1148US2016257726A1Protoxin-ii variants and methods of useJANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
- 1242US10414808B2Huwentoxin-IV variants and methods of useJANSSEN BIOTECH INC·Filed 2013·Granted Sep 17, 2019·0 cites·3 claims
- 1341US2022016215A1Gip receptor agonist peptide compounds and uses thereofTAKEDA PHAARMACEUTICAL COMPANY LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mack Flinspach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →